Overview

Study of a Single Dose of PRS-060 Administered by Oral Inhalation or IV Infusion in Healthy Subjects

Status:
Completed
Trial end date:
2018-10-11
Target enrollment:
Participant gender:
Summary
A Dose Escalating Study of PRS-060 Administered by Oral Inhalation or IV Infusion in Healthy Subjects
Phase:
Phase 1
Details
Lead Sponsor:
Pieris Australia Pty Ltd